Clinical Trials
42 trialsDNET
Asian Institute of Gastroenterology, India
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Rigshospitalet, Denmark
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
European Institute of Oncology
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Molecular Targeting Technologies, Inc.
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Radio-Marker
Erasmus Medical Center
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Fundación de investigación HM
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
University Hospital, Antwerp
Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm
Peking Union Medical College Hospital
Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma
Peking Union Medical College Hospital
LOLA
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
MetNET-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
FENET-2016
University Hospital of Ferrara
Impact of Peptides and Chelators on Somatostatin Receptor Antagonists
Peking Union Medical College Hospital
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
University of Warmia and Mazury
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
POLNETS_PRRT
University of Warmia and Mazury
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Molecular Insight Pharmaceuticals, Inc.
Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
Peking University
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
Tel-Aviv Sourasky Medical Center
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
Tel-Aviv Sourasky Medical Center
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
Peking Union Medical College Hospital
Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET
Samsung Medical Center
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)
CHU de Reims
Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue
King Faisal Specialist Hospital & Research Center
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Xiangya Hospital of Central South University
177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
Peking University
EUS
Asan Medical Center
Nonfunctional Pancreatic NET and PET Imaging
Turku University Hospital
Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
MetNet
Instituto do Cancer do Estado de São Paulo
EUS-FNA
Istituto Clinico Humanitas
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Ochsner Health System
124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.
Tel-Aviv Sourasky Medical Center
XELBEVOCT
University of Turin, Italy
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Guangdong Provincial People's Hospital